[1]
2025. A new strategy to evaluate emerging tumour-associated antigens as biomarkers of acute lymphocytic leukaemia development. Journal of Applied and Natural Science. 17, 1 (Mar. 2025), 179–185. DOI:https://doi.org/10.31018/jans.v17i1.6211.